Physician

David Christian Owens, M.D.

According to 2025 Medicare claims, David Owens, M.D. (NPI: 1780624304) practices urology in the Gulfport-Biloxi, MS market, with the plurality of this provider's patient population coming from Jackson, MS. This provider's primary affiliated billing organization is UROLOGY ASSOCIATES OF MOBILE, P.A. (NPI: 1194828368; TIN: 63-0576885) and primary practice location at 39564-3241. Owens is affiliated with the Aledade A3047 MS MSSP Enhanced (ACO ID: A3047) and CHSPSC ACO 12, LLC (ACO ID: A3722), participating under the MSSP model.

Owens' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 793 traditional Medicare patients, billed 9,052 HCPCS/CPT codes, and received $209,730 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,643 prescription claims across 679 beneficiaries totaling $622,822 in drug costs, led by Xtandi (Enzalutamide). DME data shows 49 claims. Open Payments data shows 49 records totaling $1,382. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $55,785 to $209,730. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $44,288 and ending at $622,822. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	337	632	$55,785
2021	529	1,165	$108,888
2022	605	1,188	$105,026
2023	691	1,282	$115,273
2024	793	9,052	$209,730

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	159	679	$44,288
2016	152	691	$51,077
2017	168	718	$36,023
2018	163	744	$114,299
2019	164	715	$64,116
2020	207	886	$37,645
2021	316	1,349	$175,531
2022	378	1,733	$86,785
2023	432	1,845	$71,252
2024	679	2,643	$622,822

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	45	$6,098
2016	N/R	31	$6,247
2017	N/R	15	$4,455
2018	N/R	27	$8,183
2019	N/R	18	$7,057
2020	N/R	16	$7,887
2021	N/R	20	$8,333
2022	N/R	25	$9,529
2023	N/R	86	$14,138
2024	N/R	49	$14,869

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	121	121	$150
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	518	742	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	305	347	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	514	727	$12
36415	Insertion of needle into vein for collection of blood sample	170	187	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	34	1,020	$459,114
Orgovyx	Relugolix	32	960	$81,607
Myrbetriq	Mirabegron	33	1,549	$22,386
Tamsulosin Hcl	Tamsulosin Hcl	695	57,546	$10,101
Gemtesa	Vibegron	11	570	$8,800

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	37	$14,599
A4332	Lubricant, individual sterile packet, each	N	N/R	12	$270

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$1,382	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Christian Owens, M.D.?

Tedicare shows public-source Medicare data for David Christian Owens, M.D. (NPI 1780624304), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Christian Owens, M.D. have ACO affiliation data?

David Christian Owens, M.D. is shown with ACO affiliation data for Aledade A3047 MS MSSP Enhanced (MSSP, ACO ID A3047) and CHSPSC ACO 12, LLC (MSSP, ACO ID A3722).

What billing organization is linked to David Christian Owens, M.D.?

David Christian Owens, M.D. is linked to UROLOGY ASSOCIATES OF MOBILE, P.A. (billing NPI 1194828368) in the available physician profile data.

Does David Christian Owens, M.D. have Open Payments data?

David Christian Owens, M.D. has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.